Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL963090

Cc1ncnn1-c1ccc(Nc2nc3n(n2)CC[C@](C)(O)C[C@@H]3c2ccc(F)cc2)cc1F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 13/20 0.41
PSEN2 P49810 13/20 0.41
APH1B Q8WW43 13/20 0.41
NCSTN Q92542 13/20 0.41
APH1A Q96BI3 13/20 0.41
PSENEN Q9NZ42 13/20 0.41
APP P05067 2/20 0.32
AXL P30530 1/20 0.32
CRACR2A Q9BSW2 3/20 0.31
CCNT1 O60563 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CCND3 P30281 1/20 0.31
CDK9 P50750 1/20 0.31
CDK6 Q00534 1/20 0.31
MALT1 Q9UDY8 1/20 0.31
DGAT1 O75907 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL961936 1.00 PSEN1 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL966345 0.94 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL962187 0.94 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL962031 0.94 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL962881 0.94 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL963091 0.88 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL961937 0.88 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
Trifluoroacetic Acid SCHEMBL966195 0.87 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
Trifluoroacetic Acid SCHEMBL964444 0.87 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
Trifluoroacetic Acid SCHEMBL963352 0.86 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379553-B1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL MYERS SQUIBB CO (US) 2013-06-26 EP disclosed
US-8349880-B2 Bicyclic compounds for the reduction of beta-amyloid production BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-08 US disclosed
US-20110015175-A1 Bicyclic Compounds for the Reduction of Beta-Amyloid Production BRISTOL-MYERS SQUIBB COMPANY 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015175-A1 Bicyclic Compounds for the Reduction of Beta-Amyloid Production APP, BACE1, APBA1 PSEN1 6/4885PSEN2 7/4885APH1B 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.